Market access is central to the success of the healthcare industry and to patient outcomes. The term means something different to each of these stakeholder groups and equally to individual companies, health providers or patient organisations, according to their size and needs.

The PM Society Market Access Interest Group will address the growing need for multiple stakeholders to understand their role in ‘market access’. Discussions are likely to be as diverse as the pharma/life sciences industries-patient dialogue, evidence requirements in the context of payer needs, the role of NHS liaison and the move from risk-sharing to value-based pricing. The Market Access group will also look to define, for the first time, the pharma and life sciences industries’ priority concerns relating to market access and, in time, to find practical solutions for overcoming barriers and establishing best practice.

In doing this the PM Society Market Access Interest Group will form close links with the PM Society Patient Engagement and NHS Partnerships Interest Groups. It will also draw on senior industry, NHS and patient representatives to understand how the varying needs of all the key stakeholder groups relate to ‘market access’.

Membership of the group is open to anyone with an interest in market access in its broadest sense, but the Society is particularly keen to hear from industry representatives. Please email Vivien or call 01403 264898 if you are interested in finding out more or to join the group.